Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2566688 | 0.97 | — | — | |
| SCHEMBL8611024 | 0.90 | — | — | |
| SCHEMBL6137517 | 0.83 | MAPT (0.44) | TSHRTRPV1ALDH1A1MAPTCYP3A4 | |
| SCHEMBL6137511 | 0.83 | MAPT (0.44) | TSHRTRPV1ALDH1A1MAPTCYP3A4 | |
| SCHEMBL6137524 | 0.83 | MAPT (0.44) | TSHRTRPV1ALDH1A1MAPTCYP3A4 | |
| SCHEMBL3613683 | 0.81 | — | — | |
| SCHEMBL15912049 | 0.81 | TRPV1 (0.42) | TSHRTRPV1TRPA1ALDH1A1MAPT | |
| SCHEMBL14604144 | 0.81 | TRPV1 (0.42) | TSHRTRPV1TRPA1ALDH1A1MAPT | |
| SCHEMBL15912048 | 0.81 | TRPV1 (0.42) | TSHRTRPV1TRPA1ALDH1A1MAPT | |
| SCHEMBL3905502 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011054628-A1 | ENHANCED PHOTO PROTECTION | UNILEVER PLC (GB) | 2011-05-12 | — | — | WO | disclosed |
| US-20110104082-A1 | ENHANCED PHOTO PROTECTION | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104082-A1 | ENHANCED PHOTO PROTECTION | ERCC1, PCNA, CUTA | TSHR 4481/4885TRPV1 355/4885TRPA1 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.